Kahaly, G J, Riedl, M, König, J, Pitz, S, Ponto, K, Diana, T, Kampmann, E, Kolbe, E, Eckstein, A, Moeller, L C, Führer, D, Salvi, M, Curro, N, Campi, I, Covelli, D, Leo, M, Marinò, M, Menconi, F, Marcocci, C, Bartalena, L, Perros, P, Wiersinga, W M, European Group on Graves' Orbitopathy (EUGOGO), Hegedüs, L & Brix, T 2018, ' Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO) : a randomised, observer-masked, multicentre trial ', The Lancet Diabetes & Endocrinology, vol. 6, no. 4, pp. 287-298 . https://doi.org/10.1016/S2213-8587(18)30020-2 Lancet. Diabetes and endocrinology, 6(4), 287-298. Elsevier BV